Chloroquine (CQ) has been under clinical use for several decades, and yet little is known about CQ sensing and signaling mechanisms or about their impact on various biological pathways. We employed the budding yeast Saccharomyces cerevisiae as a model organism to study the pathways targeted by CQ. Our screening with yeast mutants revealed that it targets histone proteins and histone deacetylases (HDACs). Here, we also describe the novel role of mitogen-activated protein kinases Hog1 and Slt2, which aid in survival in the presence of CQ. Cells deficient in Hog1 or Slt2 are found to be CQ hypersensitive, and both proteins were phosphorylated in response to CQ exposure. CQ-activated Hog1p is translocated to the nucleus and facilitates the expression of GPD1 (glycerol-3-phosphate dehydrogenase), which is required for the synthesis of glycerol (one of the major osmolytes). Moreover, cells treated with CQ exhibited an increase in intracellular reactive oxygen species (ROS) levels and the effects were rescued by addition of reduced glutathione to the medium. The deletion of SOD1, the superoxide dismutase in yeast, resulted in hypersensitivity to CQ. We have also observed P38 as well as P42/44 phosphorylation in HEK293T human cells upon exposure to CQ, indicating that the kinds of responses generated in yeast and human cells are similar. In summary, our findings define the multiple biological pathways targeted by CQ that might be useful for understanding the toxicity modulated by this pharmacologically important molecule.
C
hloroquine (CQ) has been used extensively for decades, but the molecular targets of CQ are still not completely known. There is evidence that CQ may affect multiple cellular processes, including activation of apoptosis, by inhibiting autophagic protein degradation (1-3) and cellular stress response pathways (4), antigen presentation (5) , and oxidative stress responses (6) . Apart from its antimalarial activity, CQ has emerged as a potential anticancer agent (2) and antifungal agent (7) (8) (9) (10) , and it is also known to possess antiviral activity (11, 12) . The cytotoxic effects of CQ have been demonstrated for tumor cells derived from different types of human cancers (2, 13, 14) . Recently, CQ has been shown to improve dengue-related symptoms in infected patients (15) . CQ also alters cell cycle-related protein expression and downregulates mitochondrial transmembrane potential in Bcap-37 cells (16) . Evidence suggests that CQ can also target the genome of the host cells by directly intercalating into double-stranded DNA without causing physical damage to the DNA (17) . Due to these diverse biological effects, CQ is also effective in the treatment of rheumatoid arthritis, systemic lupus erythematosus, and many other rheumatic and skin diseases (18) . In several cases, the fundamental molecular mechanisms of the therapeutic and hazardous effects of CQ are not well understood.
Elucidation of the underlying mechanisms by which CQ shows its effects will immensely facilitate the rational designing of advanced drug analogs. The model organism yeast Saccharomyces cerevisiae is an excellent system for discovering conserved targets of bioactive compounds (19, 20) . Recently, there have been reports of CQ activity against fungal pathogens (8, 9) . CQ has also been shown to inhibit thiamine transport in yeast as well as human cells (21) . The relationship between CQ toxicity and iron acquisition is also being studied in yeast cells (22) . Another report indicated a potential role for the yeast pleiotropic drug resistance (PDR) ABC transporter in mediating CQ sensitivity (23) . Hence, the objective of this study was to apply the yeast tool to gain new insights into CQ action.
Under stress conditions, yeast cells have developed a variety of mechanisms to give a specific and adaptive response. The cellular response to stress usually involves mitogen-activated protein kinase (MAPK) cascades, which are common and well-conserved signaling components present in both higher and lower eukaryotic cells (24) . The high-osmolarity glycerol (HOG) pathway, which is one of the conserved pathway pathways, operates mainly during osmotic stress. It is composed of membrane-associated osmosensors, an intracellular signaling pathway whose core is the Hog1 MAPK cascade, and cytoplasmic and nuclear effector members (25) . However, it has been demonstrated that CQ markedly stimulates p38 MAPK (the human homologue of yeast Hog1) activity in C6 glioma cells (26) but its effect on the HOG pathway has not been not established. The cell wall integrity (CWI) pathway is another conserved pathway which plays a central role in ensuring cell survival under various stress conditions, including cell wall damage (27) . Therefore, the present study was designed to elucidate the stress response generated by the budding yeast S. cerevisiae upon CQ exposure.
Here, we show that yeast cells exhibit an Hog1-mediated osmoresponse in the presence of CQ by inducing its phosphorylation. We also found activation of Slt2, which is a central kinase of Western blot analysis. Whole-cell extracts from untreated and CQtreated samples were prepared using the trichloroacetic acid (TCA) extraction method. Protein extracts were resolved using SDS-PAGE, and Western blotting was conducted as described earlier (34) . The following primary antibodies were used: green fluorescent protein (GFP) (catalog no. G1544; Sigma), p38/phospho-Hog1 (catalog no. 92115; Cell Signaling), and antiSlt2p-P/phospho-p42/44 MAPK (catalog no. 4370; Cell Signaling).
Isolation of total RNA and real-time PCR. Exponentially growing wild-type yeast cells (WT 1588-4C) were treated with CQ (150 mM), and cells were harvested at regular intervals (0, 30, 60, and 180 min). Total RNA was extracted by a heat/freeze phenol method as described earlier (34) . A 1-g volume of total RNA was reverse transcribed to synthesize cDNA using a High Capacity RNA-to-cDNA kit (Bio-Rad) according to the manufacturer's instructions. Real-time PCR experiments were performed by using SYBR green mix (Roche Diagnostics) in an ABI real-time PCR instrument. Melting curve analysis was performed for each primer pair, and relative changes in mRNA levels between control and treated groups were calculated by using the 2 -⌬⌬CT method (35) . The GPD1 relative mRNA level was detected by using forward primer 5=-CATTGCCA CCGAAGTCGCTC-3= and reverse primer 5=-AACCACAACCTAAGGC AACAACG-3=. ACT1 (forward primer 5=-CCTTCTGTTTTGGGTTTGG A-3= and reverse primer 5=-CGGTGATTTCCTTTTGCATT-3=) was used as the reference control gene.
Cell culture and Western blot analysis. HEK293T cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco Corporation, Carlsbad, CA) supplemented with 10% newborn bovine serum (Gibco Corporation) at 37°C and 5% CO 2 . Equal numbers of cells was treated with 50, 100, 200, and 500 M CQ for 30 min. Cells treated with 300 mM NaCl were taken as a positive control for P38 phosphorylation. Cells were harvested, lysate was prepared in radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% sodium deoxycholate, 1% NP-40, 1 mM EDTA, 0.1% SDS), and Western blot analysis was done.
RESULTS
CQ inhibits growth of S. cerevisiae in a dose-dependent manner. As an initial step toward examining the consequences of CQ treatment for S. cerevisiae cell growth, we performed a spot test assay with wild-type cells on synthetic complete agar (SCA) plates incorporated with increasing concentrations (50, 100, and 150 mM) of CQ. We have chosen concentrations of CQ similar to those which has been used on yeast cells in several published reports (22, 23, (36) (37) (38) . We used three wild-type yeast strains, namely, WT 1588-4C, BY4741, and W3031b, for performing spot tests to ensure that the effect of CQ is not dependent on a particular strain background. CQ exhibited similar growth-inhibitory effects on all WT strains (Fig. 1A) . The results obtained in spot tests were further validated by the growth curve experiment, which showed the reduction in the growth rate of yeast cells upon exposure to CQ (Fig. 1B) . To further check the viability of cells in the presence of CQ, a clonogenic assay was performed. After drug treatment, the cells were washed with drug-free medium, diluted, and then plated onto SCA plates to determine the frequency of viable cells. Our results illustrate that there was a significant decrease in the number of colonies upon treatment with CQ (150 mM) compared to the results seen with untreated samples (Fig. 1C  and D) .
Based on the above-mentioned experiments, we observed the growth-inhibitory effect of CQ, which indicated that the drug could possibly affect cell cycle progression. To validate this hypothesis, we performed FACS analysis and observed the cell cycle progression in the presence or absence of CQ. Exponentially growing yeast cells were treated with CQ (100 or 150 mM) for 3 h. , 10 Ϫ2 , 10 Ϫ3 , and 10 Ϫ4 ) in 1.0 ml of sterile double-distilled water, and a 3-l volume of each dilution was spotted on SCA control plates (untreated) or CQ plates (50, 100, and 150 mM). All plates were incubated at 30°C, and growth of the yeast strains was recorded at 48 h by scanning the plates using a HP scanner. (B) Wild-type yeast cells (WT 1588-4C) were grown in SC medium until the exponential phase was reached and then treated with 100 or 150 mM CQ for 24 h. Growth was monitored by recording the optical density at 600 nm (OD 600 ) of untreated (Un) and treated cultures at regular intervals. Error bars represent the standard deviations (SD) of the results of three independent repeats. (C) A clonogenic assay was performed by taking equal numbers of cells from untreated or CQ (150 mM)-treated cultures (3, 6 , and 9 h) and spreading the cells on solid-agar plates. The plates were incubated at 30°C, and survival was evaluated after 48 h of incubation. The representative images of plates are shown. (D) The numbers of colonies that appeared on plates were counted and are represented in the form of a bar diagram showing cell survival upon 150 mM CQ treatment for 3, 6, or 9 h. Error bars represent the SD of the results of three independent repeats. (E) Fluorescence-Cells were processed for FACS analysis. We observed that CQ exposure led to accumulation of yeast cells in the G 2 /M phase (Fig.  1E) . Furthermore, we performed FACS analysis after synchronizing cells in G 1 phase by the use of alpha factor. After synchronization, G 1 -arrested cells were released in fresh media (control) or media containing 150 mM CQ. In the control experiment, cells progressed to the G 2 phase within 60 min of release from alpha factor arrest (Fig. 1F) , while CQ treatment delayed the movement of cells from G 1 to G 2 /M (Fig. 1F) . Once cells entered the G 2 /M phase, they remained in same phase even after 360 min of release, suggesting that CQ treatment causes a delay in the cell cycle. Our results are consistent with an earlier report where it is demonstrated that CQ causes cell cycle arrest in the G 2 /M phase in breast cancer cell lines (16) , suggesting that the effects of CQ are the same in yeast and higher eukaryotes. Taken together, these results reveal that CQ is inhibitory to S. cerevisiae cell growth.
CQ targets histones and chromatin-modifying enzymes. It was previously reported that several antimalarial drugs, including CQ, regulate acetylation of histones in breast cancer cell lines (39) , suggesting that CQ might target chromatin-associated processes/ epigenetics. To understand the underlying mechanism through which CQ shows its effect on host epigenetics, we employed yeast strains harboring mutations in the histone tails, including strains with amino acid deletions in the N-terminal tail of H2A, H3, and H4. Removal of the N-terminal tail of H4 (positions 1 to 16) led to hypersensitivity to CQ, while not much growth inhibition was observed with deletion of the N-terminal tails of H2A (positions 1 to 20 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ), H3 , and H3 (1-5) ( Fig. 2A) , suggesting that histone H4 is crucial for providing resistance to this drug. We also observed mild sensitivity of H3 point mutants (H3 PKR16-18A, H3 QL19-20A, H3 SK22-23A, H3 RK26-27A, H3 SP28-30A, and H3 STG31-33A) to CQ ( Fig. 2A) . Interestingly, the H3K-Q mutant, in which the lysines at positions 4, 9, 14, 18, 23, and 27 were substituted by glutamine, was resistant to CQ whereas a moresevere growth defect was seen with the H4K-Q mutant (K5, 8, 12, 16Q). These results suggest that either deletion of the H4 N-teractivated cell sorting (FACS) analysis, showing the effect of the CQ on yeast cell cycle. Wild-type cells were cultured in SC medium to the exponential phase followed by treatment with CQ (100 or 150 mM) for 3 h. As a control, untreated cells were also grown for same duration of time. The cultured cells were sampled, and cellular DNA content was analyzed by FACS. (F) Wild-type cells were cultured in SC medium to the exponential phase and treated with alpha factor to synchronize all cells in G 1 phase. After synchronization, cells were released in either fresh (control) or 150 mM CQ-containing media. The culture was sampled at indicated time points, and cellular DNA content was analyzed by FACS. minal tail or mutation of those lysine residues leads to enhanced growth-inhibitory effects of CQ. Histone proteins are posttranslationally modified by various chromatin-modifying enzymes. Therefore, we next examined the effect of CQ on yeast mutants lacking some of the chromatin-modifying enzymes such as histone acetyl transferases (HATs) (gcn5⌬, hat1⌬, rtt109⌬, nlp3⌬ , atf2⌬, hpa2⌬, sas2⌬, and nut1⌬ mutants) or histone deacetylases (HDACs) (hos2⌬, hst3⌬, hst4⌬, hda1⌬, hda3⌬, sap30⌬, and sos3⌬  mutants) . In particular, we observed that rtt109⌬, gcn5⌬, and rpd3⌬ mutants were sensitive to CQ (Fig. 2B) . RPD3 acts as a histone deacetylase for H4 N-terminal lysine residues; the hypersensitivity to CQ exhibited by H4 K-Q, H4 (1-16), and rpd3⌬ mutants indicates that this drug was specifically activating those signaling pathways and operating through the combined action of these molecules.
Hog1 protein is phosphorylated upon exposure to CQ. On the basis of the results of a sensitivity assay (Fig. 2) , we propose that CQ might induce osmotic stress. One of the hallmarks of the osmotic stress response is the phosphorylation of Hog1; hence, we examined the effect of CQ on Hog1 phosphorylation in yeast cells. To determine whether the exposure of yeast cells to CQ results in the activation of Hog1 protein, we measured its active form, the dually phosphorylated form, by Western blot analysis using a selective antibody appropriate for the phosphorylated form of Hog1 protein. We observed increased phosphorylation of Hog1 protein with increasing concentrations of CQ (Fig. 3A) . Also, it was possible to detect phosphorylated Hog1 within 15 min of incubation with CQ, with maximum phosphorylation occurring after 60 min, after which the level of phosphorylation began to decrease (Fig.  3B) . The CQ-induced phosphorylation of Hog1 persisted for a prolonged time (at least 9 h) as revealed by Western blotting (Fig.  3B) . As a positive control, samples treated with 0.8 M NaCl were analyzed for Hog1 phosphorylation and, per previous reports (25, 40, 41) , phosphorylation of Hog1 started within 15 min and remained detectable for 60 min, after which it started to decrease.
Hog1 is a member of the MAPK family, and there are several upstream kinases which are involved in mediating the osmostress signal for hog1 through phosphorylation. We investigated the growth sensitivity of the nonessential gene deletions within the entire HOG pathway and performed spot test assays to determine its sensitivity to CQ. Yeast knockouts for sho1 and msb2 (regulatory sensors), ssk1 (upstream control system), ste50 (upstream kinase), ssk2 (MAPK kinase kinase [MAPKKK]), pbs2 (MAPK kinase [MAPKK]), hog1 (MAPK), and ptc2 (protein phosphatases) showed patterns of sensitivity to CQ similar to those seen with NaCl (Fig. 3C ). In particular, we observed that the MAPKK of Hog1 protein (Pbs2), which is activated under conditions of severe osmotic stress, was sensitive to CQ (150 mM). Interestingly, mutants with deletions of phosphatases such as Ptc1, which dephosphorylates Pbs2p, and Ptp2, which dephosphorylates Hog1p, were found to be hypersensitive to CQ but not to NaCl (Fig. 3C) , suggesting that Ptc1 and Ptp2 dephosphatase activity is indispensable to overcome CQ-induced osmotic stress. Next, we sought to evaluate the phosphorylation of Hog1 protein in HOG pathway mutants to investigate the role of these mutants in mediating Hog1 phosphorylation in response to CQ exposure. Western blotting was conducted to analyze the phosphorylation of Hog1 upon treatment with CQ or NaCl. We did not observe significant phosphorylation of Hog1 in the ssk1⌬, ssk2⌬, and pbs2⌬ strains (Fig.  3D ) upon CQ treatment, suggesting that Ssk1, Ssk2, and Pbs2 are important upstream components of the HOG pathway that are required for optimal activation of Hog1 in response to CQ-induced stress. Other mutants induced Hog1 phosphorylation in a manner somewhat similar to that exhibited in response to NaCl treatment. The results indicated that the mode of action of CQ is similar to but not exactly the same as that of NaCl in generating an osmoresponse.
A hog1⌬ mutant is sensitive to CQ. To examine the role of Hog1 protein in yeast in the presence of CQ, we examined the hog1⌬ mutant through spot tests, where serially diluted cultures were spotted on SCA plates with and without CQ. We observed that the hog1⌬ mutant was hypersensitive to CQ compared to the wild-type cells (Fig. 4A) . Apart from Hog1, there are several additional transcription factors such as Msn2, Msn4, and Hot1 which play an important role under conditions of osmotic stress (42, 43) . To explore the possible role of these different transcription factors in CQ-induced stress, we performed sensitivity assays. Interestingly, neither of the other mutants (hot1⌬ or msn2⌬/msn4⌬) showed hypersensitivity to CQ similar to that exhibited by the hog1⌬ mutant (Fig. 4A) . The growth-inhibitory effect of CQ was enhanced when the hog1⌬ mutation was combined with either msn2⌬/msn4⌬ or sko1⌬/hot1⌬/msn2⌬/msn4⌬ (Fig. 4A) , suggesting that the Hog1 protein plays a central role in providing resistance to CQ. Furthermore, we also performed growth curve analyses with wild-type and hog1⌬ yeast strains. We observed that the growth-inhibitory effect of CQ was more prominent in the absence of hog1p (Fig. 4B) . Taken together, these results indicate the requirement of Hog1 for mediating downstream signaling in response to CQ-induced stress for survival in yeast. Upon CQ exposure, phosphorylated Hog1 translocates to the nucleus, resulting in transient activation of GPD1. In response to osmotic stress, Hog1 is phosphorylated and translocated into the nucleus, where it regulates the expression of many osmoresponsive genes at the transcriptional level (44, 45) . Therefore, we desired to determine whether phosphorylated Hog1 was being translocated inside the nucleus after CQ exposure. We used a Hog1-GFP-tagged strain to perform confocal microscopy to examine untreated and CQ-treated yeast cells (30 or 60 min) and monitored the localization of Hog1. In untreated cells, Hog1 was distributed throughout the cells, while upon exposure to CQ or NaCl, the bright foci of hog1 were evident inside yeast nuclei as it colocalized with DAPI (4=,6-diamidino-2-phenylindole) (Fig.  5A) . Microscopy results indicated that upon phosphorylation, hog1 gets translocated to the nucleus. Once translocated into the nucleus, hog1 regulates expression of various osmoresponse genes (43, 46, 47) . Therefore, we confirmed the expression of one such gene, GPD1 (glycerol-3-phosphate dehydrogenase), involved in glycerol biosynthesis during osmotic stress (48) . For that purpose, wild-type yeast cells were treated with CQ (150 mM) and cells were harvested at regular intervals (0, 30, 60, and 180 min). Total RNA was extracted and reverse transcribed to cDNA. The expression of GPD1 was analyzed through real-time PCR normalized to the reference gene ACT1. We observed a 9-fold increase in the expression of GPD1 within 30 min of CQ exposure which decreased significantly at later time points (Fig. 5B) . This strongly indicates that upon CQ exposure, Hog1 not only is phosphorylated and translocated to the nucleus but is also in an enzymatically active state causing upregulation of GPD1 mRNA levels.
CQ exposure causes activation of Slt2 MAPK. Yeast MAPK pathways respond to diverse signals leading to specific physiological outcomes, but evidence of cross talk between such pathways is being reported; e.g., the HOG pathway is known to be involved in cell wall integrity (CWI) (49) . The Hog1 kinase has been recently described to operate with Slt2 in adaptation to zymolyase-mediated cell wall stress (50) . This led us to propose that CQ might also induce cell wall stress along with the osmoresponse. To validate our hypothesis, we examined the sensitivity to CQ of different members of the CWI pathway by performing spot test assays using SCA plates impregnated with 150 mM CQ or left untreated. The central kinase of the CWI pathway, Slt2, was hypersensitive to CQ , and the same strain was treated with 0.8 M NaCl (control) for 5 min, prior to visualization by confocal microscopy. DAPI was used to stain nuclei. (B) An exponentially growing wild-type yeast strain was exposed to 150 mM CQ for 3 h. Samples were taken at 0, 30, 60, and 180 min of incubation, and total mRNA was extracted and reverse transcribed to cDNA. The expression of GPD1 mRNA levels was examined by SYBR green real-time PCR. The fold change of GPD1 mRNA levels was normalized to the ACT1 reference gene levels. The error bars represent the SD of the results of three independent repeats. (Fig. 6A) , suggesting that CQ was inducing cell wall damage. We also observed that bni1⌬, wsc1⌬, swi4⌬, and rlm1⌬ mutants exhibited enhanced growth inhibition in response to CQ exposure compared to wild-type cells. Moreover, the effect of cell wall damage caused by CQ can be rescued by supplementation with 1 M sorbitol (Fig. 6B) . Interestingly, as shown in Fig. 6B , the growthinhibitory effect of CQ on the slt2⌬ mutant was rescued by addition of 1 M sorbitol only at lower doses (2 or 10 mM CQ).
Current information supports the idea that the cell wall damage-induced transcriptional responses are mainly governed by MAPK Slt2. The cellular response to cell wall stress is governed by the cell wall integrity pathway. To investigate this, activation of Slt2 by CQ was analyzed in the wild-type yeast cells. We observed that treatment with CQ caused a rapid enhancement of the levels of phosphorylated Slt2 (Fig. 6C) , as revealed by Western blotting using an antibody against the dually phosphorylated form of Slt2 MAPK. The time point kinetics demonstrated a consistent increase of Slt2 phosphorylation until 1 to 9 h of treatment with CQ. Taken together, our results describe the activation of Hog1 as well as Slt2 upon CQ exposure.
Exposure to CQ leads to generation of reactive oxygen species. Because CQ treatment causes significant growth inhibition in slt2⌬ or hog1⌬ mutants, we sought to investigate whether the sensitivity of cells to CQ is the result of the generation of reactive oxygen species (ROS). The level of ROS in yeast cells was detected by DCFH-DA (2,7-dichlorodihydrofluorescein diacetate), which is oxidized by ROS to the fluorescent chromophore DCF (2,7-dichlorofluorescein). As indicated by FACS analysis (Fig. 7A) , after treatment with CQ, the DCF fluorescence was significantly increased in the wild-type cells. To further confirm the elevated levels of ROS upon CQ exposure, we used sod1⌬ cells, which are known to be sensitive to ROS-inducing agents (51) . SOD1 is one of the main antioxidative enzymes that are generated under different stress conditions in response to ROS. We compared the growth of sod1⌬ cells to the growth of wild-type cells in the presence of 150 mM CQ, and, as shown in Fig. 7B , the sod1⌬ mutant was hypersensitive to CQ. Next, we analyzed the effect of antioxidants, such as reduced glutathione (GSH) or N-acetyl-L-cysteine (NAC), on the growth phenotype of the sod1⌬ mutant. As shown in Fig. 7B , addition of 10 mM GSH or 10 mM NAC restored the growth of the sod1⌬ mutant in the presence of CQ, suggesting the role of ROS in the toxicity exhibited by CQ.
We also analyzed the effect of the antioxidants on the growth of the slt2⌬ or hog1⌬ mutant in the presence of CQ. As shown in until saturation. Serial dilutions were made in double-distilled water. A 3-l volume of each undiluted and 10-fold serially diluted culture was spotted onto control (untreated) plates or SCA plates containing 150 mM CQ. All plates were incubated at 30°C for 48 h and photographed. (B) Exponential-phase cultures of S. cerevisiae BY4743 (wild type) and slt2⌬ slt2⌬ strains were serially diluted and spotted onto agar supplemented with increasing concentrations (2, 10, and 50 mM) of CQ in the absence or presence of 1 M sorbitol. (C) Cells were grown at 24°C to the mid-exponential phase, and cell extracts were fractionated and analyzed by Western blotting using phospho-p44/p42 MAPK antibodies to detect dually phosphorylated Slt2p. An asterisk (*) indicates that the nonspecific band appeared with phospho-p44/p42, used as a loading control, in the Western blot analysis. Calcofluor white (CFW)-treated yeast whole-cell extract was taken as a positive control. Fig. 7C and D, the addition of 10 mM GSH or 10 mM NAC restored the growth of both of the mutants in the presence of CQ. These results suggested that the growth inhibition observed in the slt2⌬ or hog1⌬ mutant in response to CQ is primarily due to generation of ROS.
CQ treatment causes phosphorylation of both P38 and P42/44 in the HEK293T human cell line. To further consolidate our results obtained with yeast cells, we analyzed the effect of CQ on the HEK293T human cell line. HEK293T cells were grown as described in Materials and Methods followed by treatment with increasing concentrations (50, 100, 200 , and 500 M) of CQ for 30 min. Our Western blotting results showed a dose-dependent increase in p38 phosphorylation (Fig. 8A) upon CQ exposure. Similarly, CQ also induces P42/44 phosphorylation (Fig. 8B ) in HEK293T cells. These results suggest that CQ activates similar kinds of responses in yeast and human cell lines.
DISCUSSION
In this study, we used yeast as a model organism as they exhibit protective responses as a consequence of various kinds of environmental stresses. We tried to understand the response of yeast to CQ and elucidated the mechanism of action of this drug. To understand the biological pathways that might be the target of CQ, we employed several yeast mutants for screening and found that the members involved in the osmoresponse and cell wall integrity are the major targets of CQ. In this report, we have shown for the first time that Hog1 and the Slt2 MAP kinase play central roles in responses to the antimalarial drug CQ.
Mammalian p38 and the yeast Hog1 protein are stress-activated kinases and were long thought to be activated exclusively by osmotic stress. But recent studies have indicated that this MAPK has in a role in mediating tolerance of a variety of stress conditions such as osmotic stress (52) , oxidative stress (53, 54) , heat stress (55) , and citric acid stress (56) . Exposure of yeast cells to high osmolarity results in rapid activation of the MAPK Hog1 protein, which coordinates the transcriptional program necessary for cell survival of osmostress (25, 57) . The primary sequences of p38 and its yeast homologue Hog1 show similarity at phosphorylation sites (52) , and that distinguishes Hog1 from most other known members of the MAPK family. Both Hog1 and p38 are tyrosine phosphorylated after extracellular changes in osmolarity (57) . Our results are consistent with earlier observations which showed that CQ markedly stimulates p38 MAPK activity in C6 glioma cells Ϫ3 , and 10 Ϫ4 ) in 1.0 ml of sterile double-distilled water and spotted onto the plates. Cells were cultured at 30°C for 48 h, and pictures were taken using an HP scanner. (26) , although direct phosphorylation of p38 was not shown previously. We have demonstrated that Hog1 and Slt2 play a key role in the yeast adaptive response to CQ challenge since the growth of hog1⌬ and slt2⌬ mutants was inhibited by exposure to CQ compared to the growth of the wild type.
To understand the molecular targets of CQ, we extended our preliminary observations by examining factors which function together with Hog1. Rpd3 is a member of a family of five related histone deacetylases in yeast that also comprise Hda1, Hos1, Hos2, and Hos3. It has been established that deletion of the gene encoding the histone deacetylase Rpd3 rendered cells osmosensitive (58) , while deleting the genes encoding the other related deacetylases did not affect cellular osmosensitivity in the presence of NaCl (58) . Rpd3 affects the regulation of a substantial number of genes in S. cerevisiae (59) . Similarly to these observations, our results show that CQ specifically targeted Rpd3 whereas other deacetylases were not affected ( Fig. 2A) , suggesting that genes regulated specifically by Rpd3 are required to provide tolerance of CQ-induced stress. These results also indicate that CQ-induced stress closely resembles osmostress generated due to NaCl. Rpd3 mainly deacetylates acetyl groups in histones H3 and H4 (60) . Previously, Rahim and Strobl (39) demonstrated that CQ stimulates histone hyperacetylation. Similarly, our study also revealed that histone H4 (K-Q) mutant growth was completely abolished in the presence of CQ ( Fig. 2A) , suggesting that Rpd3 deacetylates H4 N-terminal lysine residues to regulate the downstream target genes which are required to confer tolerance of stress generated by CQ treatment. Our results are consistent with an earlier observation where a histone H4 (K-Q) and rpd3⌬ mutant strains were found to be osmosensitive (58) , suggesting that CQ was inducing osmotic stress similar to that induced by NaCl. The osmotic stressinduced Hog1 phosphorylation declined after 60 min of NaCl exposure, while the CQ-induced Hog1 phosphorylation peaked at 60 to 120 min and persisted for a prolonged duration of 9 h (Fig.  3B) . Based on earlier reported results, it has been well established that different osmotically active substances exhibit different kinetics of hog1 phosphorylation, subcellular translocation, and gene expression profiles (43, (61) (62) (63) . On the other hand, apart from this kinetic difference, the stress response to CQ exposure and to high osmolarity (NaCl) in yeast appears to follow a comparable Hog1-dependent pathway. In contrast, other types of stress conditions (exposure to weak organic acids, ethanol, metalloid salts, or heat) do not lead to importation of phosphorylated Hog1 into the nucleus (44, 61, 64) , while we observed that CQ efficiently brings about the translocation of phosphorylated Hog1 protein into the nucleus.
As a result of phosphorylation, Hog1 gets translocated into the nucleus (44, 61) , where it targets various transcription factors, leading to a change of gene expression (43, 46, 47) . Notably, glycerol-3-phosphate dehydrogenase encoded by GPD1, required for the synthesis of a major osmolyte glycerol, is overexpressed (65) . Elevated glycerol production is a prerequisite for the adaptation of S. cerevisiae to hyperosmotic stress (66) (67) (68) . Most importantly, for the first time, we report that exposure of S. cerevisiae to CQ leads to Hog1 phosphorylation, followed by its translocation to the nucleus, leading to the activation of GPD1 gene expression (Fig. 5) . Although we have observed the induction of an increase in the GPD1 mRNA level upon CQ exposure, whether there is a subsequent increase in intracellular glycerol levels needs to be tested. Our results are consistent with previous reports in which osmotic swelling of acidic organelles was found upon treatment with CQ in rat hepatocytes (69) .
It was previously reported that osmotic stress and cell wall damage are closely related (49) . Consistent with that, we have demonstrated that CQ treatment induced the activation of Slt2 along with Hog1, suggesting that both of the pathways contribute to the growth-inhibitory effect of CQ. Our results are consistent with a recently reported study by Islahudin et al. (70) , in which they demonstrated that CQ causes cell wall perturbation. Here, we have provided additional insight by demonstrating that Slt2, which is a central member of cell wall integrity MAPK pathway, is phosphorylated upon CQ treatment. In yeast, Slt2 is known to be activated under conditions that stress the cell surface, such as hypo-osmotic shock, growth at high temperatures, actin perturba- tion, polarized growth, and the presence of compounds or mutations that interfere with cell wall biosynthesis (71) . Furthermore, we have also identified an increase in the level of reactive oxygen species (ROS) as one of the reasons behind the growth inhibition of yeast cells caused by CQ. Previously, it was reported that CQ increases the intracellular level of ROS in human astroglial cells (6) as well as in a host-parasite system (72, 73) , and those reports are consistent with our study on yeast cells.
To further substantiate our study results, we analyzed the effects of CQ on the HEK293T human cell line. P38 (human orthologue of yeast Hog1) and P42/44 (human orthologue of yeast Slt2) were phosphorylated in response to CQ exposure (Fig. 8) . These results suggest that similar kinds of responses to CQ exposure are generated in yeast and human cells. Our work is primarily based on a model system, S. cerevisiae, and the CQ concentrations used in this system are higher than those required to kill malarial parasites. However, CQ is accumulated in the parasite food vacuole to millimolar concentrations similar to those used in these experiments, and thus, this work may have some biological relevance to the in vivo parasite system (74, 75 ). We have not tested our hypothesis on malarial parasites; hence, the effect of CQ on Hog1 and Slt2 homologues of malarial parasites should be analyzed in future studies. In conclusion, our present findings can be summarized in a model depicting the proposed molecular mode of action of CQ in S. cerevisiae (Fig. 9) . Here, we have shown that CQ targets histone proteins and the modifying enzymes, including HATs and HDACs. Our study also revealed that CQ causes activation of the osmotic stress response as well as cell wall damage. Based on our results, we can conclude that CQ causes ROS generation leading to cell wall damage which eventually gives rise to an imbalance in the osmotic potential, causing activation of the osmotic response. Moreover, Hog1 and Slt2 are phosphorylated in response to CQ exposure. Activated Hog1 gets translocated to the nucleus, where it regulates expression of genes, leading to cell survival. Taken together, our data indicate that the HOG and CWI pathways are essential for providing resistance to CQ-induced stress. Further analysis of global and gene-specific changes in response to CQ exposure will give more insights into the mechanisms of toxicity exhibited by them. We anticipate that these facts would assist development of better approaches for assessment of toxicity caused by the pharmacologically important drug CQ.
